Citi Downgrades Novavax (NVAX) to Neutral
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $4.19 +2.95%
Rating Summary:
9 Buy, 4 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
9 Buy, 4 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Citi downgraded Novavax (NASDAQ: NVAX) from Buy to Neutral.
For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.
Shares of Novavax closed at $8.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- JPMorgan Downgrades MP Materials (MP) to Neutral
- JPMorgan Downgrades Hanwha Solutions Corp (009830:KS) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
